Influence of aging on serum cholesterol levels in heterozygous familial hypercholesterolemia patients with long-term LDL apheresis therapy

被引：0
|
作者：
Miwa, K
Toudou, Y
Kawashiri, M
Higashikata, T
Inazu, A
Koizumi, J
Mabuchi, H
机构：
[1] Kanazawa Univ, Grad Sch, Kanazawa, Ishikawa 920, Japan
[2] Kanazawa Univ, Grad Sch Hlth Sci, Kanazawa, Ishikawa 920, Japan
[3] Kanazawa Univ, Dept Gen Med, Kanazawa, Ishikawa 920, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(03)90747-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [41] Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia
    Mabuchi, H
    Higashikata, T
    Kawashiri, M
    TRANSFUSION AND APHERESIS SCIENCE, 2004, 30 (03) : 233 - 243
  • [42] POLYUNSATURATED FATTY ACIDS REDUCE LEVELS OF LDL AND TRIGLYCERIDES IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Hande, L.
    Kjellmo, C.
    Pettersen, K.
    Thunhaug, H.
    Enebakk, T.
    Hovland, A.
    Lappegard, K. T.
    ATHEROSCLEROSIS, 2018, 275 : E178 - E179
  • [43] How much further do we need to decrease LDL cholesterol levels in heterozygous familial hypercholesterolemia?
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2019, 284 : 218 - 220
  • [44] Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia
    Athyros, VG
    Papageorgiou, AA
    Kontopoulos, AG
    ATHEROSCLEROSIS, 2002, 163 (01) : 205 - 206
  • [45] Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia
    Makino, H
    Harada-Shiba, T
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (04) : 397 - 401
  • [46] Impact of evolocumab, a PCSK9 inhibitor, withdrawing from regular ldl-apheresis therapy in patients with heterozygous familial hypercholesterolemia
    Kawashiri, M.
    Higashikata, T.
    Nohara, A.
    Nakanishi, C.
    Tada, H.
    Okada, H.
    Yamagishi, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1331 - 1331
  • [47] Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
    Santos, Raul D.
    Stein, Evan A.
    Hovingh, G. Kees
    Blom, Dirk J.
    Soran, Handrean
    Watts, Gerald F.
    Lopez, J. Antonio G.
    Bray, Sarah
    Kurtz, Christopher E.
    Hamer, Andrew W.
    Raal, Frederick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (06) : 565 - 574
  • [48] Long-term efficacy of LDL-apheresis on coronary heart disease in familial hypercholesterolemic patients
    Mabuchi, H
    Koizumi, J
    Shimizu, M
    Kajinami, K
    Miyamoto, S
    Ueda, K
    Takegoshi, T
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 58 - 58
  • [49] EFFECT OF LONG-TERM PROBUCOL TREATMENT ON SERUM-LIPOPROTEINS AND SKIN XANTHOMAS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    WATANABE, A
    MABUCHI, H
    SAKAI, Y
    SAKAI, T
    YOSHIMURA, A
    WAKASUGI, T
    KOIZUMI, J
    MIYAMOTO, S
    TAKEDA, R
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 183 : 471 - 471
  • [50] Insufficient long-term LDL-cholesterol management in patients with familial hypercholesterolemia 5 years after an acute coronary syndrome
    Krasieva, K.
    Gencer, B.
    Carballo, D.
    Muller, O.
    Fournier, S.
    Matter, C.
    Luescher, T.
    Raeber, L.
    Rodondi, N.
    Mach, F.
    Nanchen, D.
    EUROPEAN HEART JOURNAL, 2023, 44
12345